Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots... Show more
PEN is expected to report earnings to rise 7.78% to 92 cents per share on October 29
Q3'25
Est.
$0.93
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.16
The last earnings report on July 29 showed earnings per share of 86 cents, beating the estimate of 82 cents. With 425.20K shares outstanding, the current market capitalization sits at 10.78B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PEN showed earnings on July 29, 2025. You can read more about the earnings report here.